ERS transformative deals

ERS offers "read and publish" agreements for institutions or consortia, enabling APC-free publishing in the European Respiratory Journai, European Respiratory Review and ERJ Open Research, along with access to all subscription content in the European Respiratory Journal (the other two journals are wholly open access). Agreements can cover one year or longer.

If you would like to discuss a read and publish arrangement for your institution or consortium, please contact our subscriptions team: subscriptions@ersnet.org

• EIFL (worldwide)
• Jisc (United Kingdom)
• Tel Aviv University (Israel)
• University of Groningen and University Medical Center Groningen (Netherlands)
• University of New South Wales (Australia)

EIFL

Beginning in 2021, ERS has a “read and publish” arrangement with Electronic Information for Libraries (EIFL) to improve access to the ERS journals for institutions in 37 countries. Initially this covers the European Respiratory Journal only, but from the beginning of 2024 it will also include ERJ Open Research and the European Respiratory Review.

Authors in the following countries will be able to publish their article open access, with a CC-BY licence, at no cost:

Albania	Kenya	North Macedonia
Armenia	Kosovo	Palestine
Azerbaijan	Kyrgyzstan	Senegal
Belarus	Laos	Serbia
Botswana	Lesotho	Sudan
Congo (Democratic Republic)	Malawi	Tanzania
Ethiopia	Maldives	Uganda
Fiji	Moldova	Ukraine
Georgia	Myanmar	Uzbekistan
Ghana	Namibia	Zambia
Ivory Coast	Nepal	Zimbabwe

In addition, institutions in the above countries can apply for free "read" access to all ERJ content online by contacting EIFL (https://eifl.net/publisher/european-respiratory-society).

Institutions in the following countries can apply to be part of the read-and-publish deal for a reduced fee. Corresponding authors may wish to discuss this with their library’s acquisitions team prior to submission:

• Estonia
• Latvia
• Lithuania
• Slovenia

To be eligible for free open access publishing under this offer, articles must meet the following conditions:

• Be any article type other than a European Respiratory Journal Editorial
• For country-based eligibility: have a corresponding author whose e-mail address or primary affiliation (in their ScholarOne Manuscripts account) indicates a country that corresponds to one of the countries listed as eligible for free read and publish
• Have a corresponding author whose email address (on their ScholarOne account and the to-be-published article) is issued by one of the participating institutions OR whose affiliation has been recognised by ScholarOne Manuscripts as belonging to one of those institutions. If there is a yellow alert symbol next to the institution in your account details, it has not been recognised.

Be accepted for publication between 1 January 2020 and 31 December 2026.

Jisc

ERS has entered into a "transformative deal" with the UK umbrella body Jisc.

Under the terms of the arrangement, eligible articles in one or more ERS journals will be published under a CC-BY open access licence at no cost to the author: https://creativecommons.org/licenses/by/4.0/

To be eligible, articles must meet the following conditions: 

• Be any article type other than a European Respiratory Journal Editorial, an official ERS document or an article which ERS is prevented from publishing open access by another rightsholder. 
• Have a corresponding author whose email address (on their ScholarOne account and the to-be-published article) is issued by one of the participating institutions OR whose affiliation has been recognised by ScholarOne Manuscripts as belonging to one of those institutions. If there is a yellow alert symbol next to the institution in your account details, it has not been recognised.
• Be accepted between 1 January 2022 and 31 December 2024, inclusive

Participating institutions

• Cardiff University (European Respiratory Journal): https://www.cardiff.ac.uk/
• Imperial College (European Respiratory Journal): https://www.imperial.ac.uk
• Lancaster University (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.lancaster.ac.uk/​
• Queen Mary University of London (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.qmul.ac.uk/​
• Queen's University Belfast (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.qub.ac.uk/
• St George's, University of London (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.sgul.ac.uk/
• Ulster University (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.ulster.ac.uk/
• University of Birmingham (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.bham.ac.uk/
• University of Bristol (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.bristol.ac.uk/
• University of Cambridge (European Respiratory Journal): https://www.cam.ac.uk/
• University of Edinburgh (European Respiratory Journal): https://www.ed.ac.uk
• University of Exeter (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.exeter.ac.uk/
• University of Leicester (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://le.ac.uk/
• University of Liverpool (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.liverpool.ac.uk/
• University of Nottingham (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.nottingham.ac.uk/
• University of Oxford (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.ox.ac.uk
• University of Reading (European Respiratory Journal, European Respiratory Review, ERJ Open Research): https://www.reading.ac.uk/

Tel Aviv University

Beginning in 2022, ERS has a read-and-publish agreement with Tel Aviv University (https://www.tau.ac.il), covering the European Respiratory Journal, European Respiratory Review and ERJ Open Research. Under the terms of the arrangement, eligible articles in the three participating ERS journals will be published under a CC-BY open access licence at no cost to the author: https://creativecommons.org/licenses/by/4.0/.

To be eligible for free open access publishing under this offer, articles must meet the following conditions: